廣盛原中(zhong)(zhong)(zhong)(zhong)醫藥肇(zhao)啟于(yu)明(ming)萬(wan)歷(li)八年(nian)(1580),是一家(jia)以(yi)“讓中(zhong)(zhong)(zhong)(zhong)醫藥回歸為(wei)(wei)生(sheng)活方式(shi)”為(wei)(wei)愿景,以(yi)“讓年(nian)青(qing)人愛上中(zhong)(zhong)(zhong)(zhong)醫藥”為(wei)(wei)使命,以(yi)“炮制之(zhi)繁無以(yi)復加、取利之(zhi)薄無以(yi)復減”為(wei)(wei)價值觀的中(zhong)(zhong)(zhong)(zhong)醫藥企業(ye)。其前身為(wei)(wei)1956年(nian)公私合營的大同中(zhong)(zhong)(zhong)(zhong)藥廠,2019年(nian)10月25日“全(quan)國中(zhong)(zhong)(zhong)(zhong)醫藥大會”當天(tian),廣盛原盛世重光,成為(wei)(wei)國內由中(zhong)(zhong)(zhong)(zhong)藥廠升級為(wei)(wei)全(quan)國性(xing)“中(zhong)(zhong)(zhong)(zhong)醫藥”公司的企業(ye)。
公司擁有膠囊劑、顆粒劑、散劑、糖漿劑、片劑、丸劑(大蜜丸、水丸、水蜜丸、濃縮丸、微丸)、中藥飲片、特醫食品等生產線,共有藥品批文167個。廣盛(sheng)原中醫(yi)藥以(yi)“資源、科技(ji)、文化”為(wei)核心競爭(zheng)力(li),布局(ju)以(yi)“廣盛(sheng)原中醫(yi)生(sheng)活”為(wei)體、“精品國藥”和“本草生(sheng)活”為(wei)用(yong)的(de)產業體系,推進合(he)伙(huo)人創業機(ji)制,使廣盛(sheng)原成為(wei)開放、融合(he)的(de)中醫(yi)藥資源整(zheng)合(he)平臺(tai)。